164 related articles for article (PubMed ID: 24639126)
1. Cytotoxic efficacy of a novel dinuclear platinum(II) complex used with anti-MUC1 in human breast cancer cells.
Gornowicz A; Kałuża Z; Bielawska A; Gabryel-Porowska H; Czarnomysy R; Bielawski K
Mol Cell Biochem; 2014 Jul; 392(1-2):161-74. PubMed ID: 24639126
[TBL] [Abstract][Full Text] [Related]
2. The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells.
Gornowicz A; Bielawska A; Czarnomysy R; Gabryel-Porowska H; Muszyńska A; Bielawski K
Mol Cell Biochem; 2015 Oct; 408(1-2):103-13. PubMed ID: 26112902
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of anticancer action of novel berenil complex of platinum(II) combined with anti-MUC1 in MCF-7 breast cancer cells.
Gornowicz A; Bielawska A; Szymanowski W; Gabryel-Porowska H; Czarnomysy R; Bielawski K
Oncol Lett; 2018 Feb; 15(2):2340-2348. PubMed ID: 29434943
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells.
Bielawska A; Popławska B; Surazyński A; Czarnomysy R; Bielawski K
Eur J Pharmacol; 2010 Sep; 643(1):34-41. PubMed ID: 20598681
[TBL] [Abstract][Full Text] [Related]
5. The effect of a novel dinuclear platinum complex with berenil and 2-picoline ligands on growth of human breast cancer cells.
Bielawski K; Bielawska A; Popławska B; Surazyński A; Czarnomysy R
Acta Pol Pharm; 2010; 67(6):609-14. PubMed ID: 21229875
[TBL] [Abstract][Full Text] [Related]
6. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
[No Abstract] [Full Text] [Related]
7. Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum(II) complexes.
Bielawski K; Czarnomysy R; Muszyńska A; Bielawska A; Popławska B
Environ Toxicol Pharmacol; 2013 Mar; 35(2):254-64. PubMed ID: 23376176
[TBL] [Abstract][Full Text] [Related]
8. Anti-growth effect of a novel trans-dichloridobis[2-(2-hydroxyethyl)pyridine]platinum (II) complex via induction of apoptosis on breast cancer cell lines.
Oral AY; Cevatemre B; Sarimahmut M; Icsel C; Yilmaz VT; Ulukaya E
Bioorg Med Chem; 2015 Aug; 23(15):4303-4310. PubMed ID: 26143341
[TBL] [Abstract][Full Text] [Related]
9. Dinuclear berenil-platinum (II) complexes as modulators of apoptosis in human MCF-7 and MDA-MB231 breast cancer cells.
Agnieszka G; Ewa A; Anna B; Krzysztof B; Monika C; Elżbieta S
Anticancer Agents Med Chem; 2014; 14(8):1179-86. PubMed ID: 24954860
[TBL] [Abstract][Full Text] [Related]
10. A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells.
Czarnomysy R; Surażyński A; Muszynska A; Gornowicz A; Bielawska A; Bielawski K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1006-1023. PubMed ID: 29862867
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and evaluation of cis-diphenyl pyridineamine platinum(II) complexes as potential anti-breast cancer agents.
Varela JG; De Chatterjee A; Guevara P; Ramirez V; Metta-Magaña AJ; Villagrán D; Varela-Ramirez A; Das S; Nuñez JE
J Biol Inorg Chem; 2014 Aug; 19(6):967-979. PubMed ID: 24737042
[TBL] [Abstract][Full Text] [Related]
12. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of the anti-KL-6/MUC1 monoclonal antibody through exposure of surface molecules by MUC1 capping.
Doi M; Yokoyama A; Kondo K; Ohnishi H; Ishikawa N; Hattori N; Kohno N
Cancer Sci; 2006 May; 97(5):420-9. PubMed ID: 16630141
[TBL] [Abstract][Full Text] [Related]
14. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
[TBL] [Abstract][Full Text] [Related]
16. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
[TBL] [Abstract][Full Text] [Related]
18. MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells.
Fessler SP; Wotkowicz MT; Mahanta SK; Bamdad C
Breast Cancer Res Treat; 2009 Nov; 118(1):113-24. PubMed ID: 19415485
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
[TBL] [Abstract][Full Text] [Related]
20. Novel dinuclear platinum(II) complexes targets NFkappaB signaling pathway to induce apoptosis and inhibit metabolism of MCF-7 breast cancer cells.
Popławska B; Bielawska A; Surazyński A; Czarnomysy R; Bielawski K
Folia Histochem Cytobiol; 2009; 47(5):S141-6. PubMed ID: 20067886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
